COSMO Pharmaceuticals SA (COPN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-12.70 Million ≈ $-16.06 Million USD) by net assets (CHF488.80 Million ≈ $617.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

COSMO Pharmaceuticals SA - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how COSMO Pharmaceuticals SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read COSMO Pharmaceuticals SA total liabilities for a breakdown of total debt and financial obligations.

COSMO Pharmaceuticals SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yapp Automotive Systems Co Ltd
SHG:603013
0.065x
Bio-Rad Laboratories Inc
NYSE:BIO-B
0.016x
MD Pictures Tbk PT
JK:FILM
-0.015x
Acadia Healthcare Company Inc
NASDAQ:ACHC
0.022x
QCR Holdings Inc
NASDAQ:QCRH
0.043x
Hyundai Green Food Co Ltd
KO:005440
0.008x
Guangdong Homa Appliances Co Ltd
SHE:002668
0.117x
Harrow Health Inc
NASDAQ:HROW
0.356x

Annual Cash Flow Conversion Efficiency for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see COSMO Pharmaceuticals SA (COPN) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF488.80 Million
≈ $617.97 Million
CHF-11.62 Million
≈ $-14.69 Million
-0.024x -107.39%
2024-12-31 CHF505.09 Million
≈ $638.57 Million
CHF162.41 Million
≈ $205.33 Million
0.322x +507.52%
2023-12-31 CHF429.04 Million
≈ $542.42 Million
CHF22.71 Million
≈ $28.71 Million
0.053x -26.12%
2022-12-31 CHF463.79 Million
≈ $586.35 Million
CHF33.23 Million
≈ $42.01 Million
0.072x +191.24%
2021-12-31 CHF512.68 Million
≈ $648.16 Million
CHF12.61 Million
≈ $15.94 Million
0.025x -24.20%
2020-12-31 CHF400.12 Million
≈ $505.87 Million
CHF12.98 Million
≈ $16.42 Million
0.032x +167.80%
2019-12-31 CHF393.73 Million
≈ $497.78 Million
CHF-18.85 Million
≈ $-23.83 Million
-0.048x -109.50%
2018-12-31 CHF444.85 Million
≈ $562.42 Million
CHF-10.16 Million
≈ $-12.85 Million
-0.023x -7.32%
2017-12-31 CHF470.12 Million
≈ $594.35 Million
CHF-10.01 Million
≈ $-12.65 Million
-0.021x -133.50%
2016-12-31 CHF415.56 Million
≈ $525.38 Million
CHF26.41 Million
≈ $33.39 Million
0.064x +165.40%
2015-12-31 CHF403.65 Million
≈ $510.32 Million
CHF-39.23 Million
≈ $-49.59 Million
-0.097x -122.27%
2014-12-31 CHF152.29 Million
≈ $192.53 Million
CHF66.45 Million
≈ $84.01 Million
0.436x +1084.01%
2013-12-31 CHF220.16 Million
≈ $278.34 Million
CHF8.11 Million
≈ $10.26 Million
0.037x -80.04%
2012-12-31 CHF124.60 Million
≈ $157.53 Million
CHF23.00 Million
≈ $29.08 Million
0.185x +3.72%
2011-12-31 CHF63.43 Million
≈ $80.20 Million
CHF11.29 Million
≈ $14.27 Million
0.178x +33.42%
2010-12-31 CHF58.37 Million
≈ $73.79 Million
CHF7.79 Million
≈ $9.84 Million
0.133x +105.80%
2009-12-31 CHF59.80 Million
≈ $75.60 Million
CHF3.88 Million
≈ $4.90 Million
0.065x +122.39%
2008-12-31 CHF43.24 Million
≈ $54.66 Million
CHF-12.52 Million
≈ $-15.82 Million
-0.290x -303.62%
2007-12-31 CHF35.15 Million
≈ $44.44 Million
CHF-2.52 Million
≈ $-3.19 Million
-0.072x -106.31%
2006-12-31 CHF5.34 Million
≈ $6.76 Million
CHF6.08 Million
≈ $7.68 Million
1.137x -57.78%
2005-12-31 CHF631.00K
≈ $797.75K
CHF1.70 Million
≈ $2.15 Million
2.694x +1008.37%
2004-12-31 CHF-880.00K
≈ $-1.11 Million
CHF261.00K
≈ $329.97K
-0.297x --

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General
Market Cap
$1.78 Billion
CHF1.40 Billion CHF
Market Cap Rank
#7338 Global
#101 in Switzerland
Share Price
CHF82.00
Change (1 day)
-0.36%
52-Week Range
CHF48.35 - CHF124.80
All Time High
CHF171.24
About

Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris;… Read more